Plus Therapeutics (PSTV) announces the appointment of Kyle Guse, to the Company’s Board of Directors where he will serve as chair of the Audit Committee and on the Compensation Committee. Currently, he serves as Chief Legal Officer of DDC Enterprise (DDC).
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PSTV:
- Plus Therapeutics Appoints Kyle Guse to Board
- Plus Therapeutics presents data highlighting clinical benefit, safety of REYOBIQ
- Plus Therapeutics (PSTV) Q1 Earnings Cheat Sheet
- Plus Therapeutics files to sell 1.57B shares of common stock for holders
- Promising Outlook for Plus Therapeutics: Buy Rating Affirmed Amid Clinical and Financial Advancements